单克隆抗体组合在1981 - 1990年波兰脊髓灰质炎病毒学和流行病学回顾中的应用
Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.
作者信息
Jarzabek Z, Zabicka J, John A, Howlett J, Dunn G, Wood D J
机构信息
Department of Virology, National Institute of Hygiene, Warsaw, Poland.
出版信息
Bull World Health Organ. 1992;70(3):327-33.
Abstract
Monoclonal antibody panels developed to differentiate vaccine-derived and wild-type strains of polio-viruses were applied to isolates from cases of paralytic poliomyelitis, non-paralytic poliomyelitis, and healthy excreters of poliovirus from Poland. All isolates from poliomyelitis cases were shown to be vaccine-derived, as were most other strains. However, two strains associated with meningitis had wild-type antigenic phenotypes and, as shown by partial genomic sequencing, wild-type genotypes. Correlation of laboratory and epidemiological data suggested that residual cases of paralytic poliomyelitis in Poland between 1981 and 1990 were vaccine-related. Study of the non-paralytic cases, however, helped identify the circulation of endemic wild-type viruses in a well-vaccinated community.
摘要
为区分脊髓灰质炎病毒的疫苗衍生株和野生型株而研发的单克隆抗体组，被应用于来自波兰麻痹性脊髓灰质炎病例、非麻痹性脊髓灰质炎病例以及脊髓灰质炎病毒健康排泄者的分离株。所有脊髓灰质炎病例的分离株均显示为疫苗衍生株，其他大多数毒株也是如此。然而，两株与脑膜炎相关的毒株具有野生型抗原表型，并且如部分基因组测序所示，具有野生型基因型。实验室数据与流行病学数据的相关性表明，1981年至1990年间波兰残留的麻痹性脊髓灰质炎病例与疫苗有关。然而，对非麻痹性病例的研究有助于确定在一个疫苗接种良好的社区中地方性野生型病毒的传播情况。
相似文献
1
Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.单克隆抗体组合在1981 - 1990年波兰脊髓灰质炎病毒学和流行病学回顾中的应用
Bull World Health Organ. 1992;70(3):327-33.
2
Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.白俄罗斯的疫苗相关麻痹性脊髓灰质炎及其他伴有急性弛缓性麻痹综合征的疾病
Cent Eur J Public Health. 2003 Dec;11(4):213-8.
3
Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.自三价口服脊髓灰质炎疫苗引入以来挪威的麻痹性脊髓灰质炎：一项流行病学和病毒学研究
Bull World Health Organ. 1971;45(6):733-9.
4
Decision analysis in planning for a polio outbreak in the United States.美国脊髓灰质炎疫情应对规划中的决策分析
Pediatrics. 2006 Aug;118(2):611-8. doi: 10.1542/peds.2005-2358.
5
Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.使用口服脊髓灰质炎疫苗阻断野生脊髓灰质炎病毒传播：印度高危地区的环境监测
J Med Virol. 2008 Aug;80(8):1477-88. doi: 10.1002/jmv.21230.
6
Intratypic characterization of poliovirus type 1 isolates.脊髓灰质炎病毒1型分离株的型内特征分析
Indian J Med Res. 1991 Jul;93:202-7.
7
8
Immunization against poliomyelitis: risk/benefit/cost in a changing context.脊髓灰质炎免疫接种：不断变化背景下的风险/益处/成本
Dev Biol Stand. 1979;43:151-7.
9
The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.在全球根除脊髓灰质炎行动战略计划框架内，罗马尼亚对急性弛缓性麻痹（AFP）病例开展基于实验室的主动监测。
Roum Arch Microbiol Immunol. 2007 Jan-Jun;66(1-2):44-50.
10
[Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].[从脊髓灰质炎患者中分离脊髓灰质炎病毒重组疫苗株]
Mol Gen Mikrobiol Virusol. 1989 Nov(11):14-20.
引用本文的文献
1
Detection of vaccine-derived poliovirus type 2 from sewage samples and public health response, Poland, November to December 2024.2024年11月至12月，波兰从污水样本中检测出2型疫苗衍生脊髓灰质炎病毒及公共卫生应对措施
Euro Surveill. 2025 Jan;30(1). doi: 10.2807/1560-7917.ES.2025.30.1.2400805.
2
Investigation of airport sewage to detect importation of poliovirus, Poland, 2017 to 2020.调查机场污水以检测脊髓灰质炎病毒的输入，波兰，2017 年至 2020 年。
Euro Surveill. 2022 Jun;27(24). doi: 10.2807/1560-7917.ES.2022.27.24.2100674.
3
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.肠道病毒的分子分型：现状与未来需求。欧盟病毒性脑膜炎和脑炎联合行动。
Clin Microbiol Rev. 1998 Jan;11(1):202-27. doi: 10.1128/CMR.11.1.202.
4
Comparative study of five methods for intratypic differentiation of polioviruses.脊髓灰质炎病毒型内鉴别五种方法的比较研究
J Clin Microbiol. 1995 Oct;33(10):2562-6. doi: 10.1128/jcm.33.10.2562-2566.1995.
5
Reverse transcription multiplex PCR for differentiation between polio- and enteroviruses from clinical and environmental samples.用于区分临床和环境样本中脊髓灰质炎病毒和肠道病毒的逆转录多重聚合酶链反应
J Clin Microbiol. 1995 Jun;33(6):1442-7. doi: 10.1128/jcm.33.6.1442-1447.1995.
本文引用的文献
1
Antigenic analysis of polioviruses by kinetic studies of serum neutralization.通过血清中和动力学研究对脊髓灰质炎病毒进行抗原分析。
Virology. 1959 Jan;7(1):45-58. doi: 10.1016/0042-6822(59)90176-x.
2
Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States.美国常规脊髓灰质炎免疫中序贯使用灭活脊髓灰质炎疫苗和减毒活脊髓灰质炎疫苗的基本原理。
Pediatr Infect Dis J. 1987 Oct;6(10):881-7. doi: 10.1097/00006454-198710000-00001.
3
Safety of oral poliomyelitis vaccine: results of a WHO enquiry.口服脊髓灰质炎疫苗的安全性：世界卫生组织调查结果
Bull World Health Organ. 1988;66(6):739-46.
4
WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.世界卫生组织关于使用单克隆抗体进行脊髓灰质炎病毒株型内鉴别诊断的合作研究。
Bull World Health Organ. 1986;64(2):239-46.
5
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.与Sabin 3型脊髓灰质炎疫苗基因组非编码区单核苷酸变化相关的神经毒力增加。
Nature. 1985;314(6011):548-50. doi: 10.1038/314548a0.
6
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.一种针对麻痹性脊髓灰质炎病例的新的流行病学和实验室分类系统。
Am J Public Health. 1989 Apr;79(4):495-8. doi: 10.2105/ajph.79.4.495.
7
Geographic distribution of wild poliovirus type 1 genotypes.1型野生脊髓灰质炎病毒基因型的地理分布。
Virology. 1987 Oct;160(2):311-22. doi: 10.1016/0042-6822(87)90001-8.
8
Poliovaccine virus in the cerebrospinal fluid after oral polio vaccination.
J Infect. 1989 Sep;19(2):173-6. doi: 10.1016/s0163-4453(89)92014-8.
9
Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.
J Gen Virol. 1986 Apr;67 ( Pt 4):693-706. doi: 10.1099/0022-1317-67-4-693.
10
Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources.来自两个来源的口服脊髓灰质炎减毒活疫苗初次接种后婴儿的病毒排泄和变异情况。
J Med Virol. 1990 Oct;32(2):92-5. doi: 10.1002/jmv.1890320205.
Zotero 插件